Quantum Genomics Société Anonyme (OTCMKTS:QNNTF) Short Interest Update

Quantum Genomics Société Anonyme (OTCMKTS:QNNTFGet Free Report) was the recipient of a large decline in short interest in October. As of October 31st, there was short interest totalling 800 shares, a decline of 98.0% from the October 15th total of 39,700 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

Quantum Genomics Société Anonyme Stock Performance

QNNTF remained flat at $0.10 during trading on Thursday. Quantum Genomics Société Anonyme has a fifty-two week low of $0.10 and a fifty-two week high of $0.10. The business has a 50 day moving average of $0.10 and a 200-day moving average of $0.10.

Quantum Genomics Société Anonyme Company Profile

(Get Free Report)

Quantum Genomics Société Anonyme, a biopharmaceutical company, engages in the development of drugs to treat cardiovascular diseases. The company develops its drugs based on brain inhibition mechanism of Aminopeptidase A: BAPAI, a triple-action therapeutic platform primarily to treat high blood pressure and heart failure.

See Also

Receive News & Ratings for Quantum Genomics Société Anonyme Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum Genomics Société Anonyme and related companies with MarketBeat.com's FREE daily email newsletter.